Skip to main content
Dryad

Bespoke plant glycoconjugates for gut microbiota-mediated drug targeting

Data files

Mar 07, 2025 version files 899.83 MB

Click names to download individual files

Abstract

The gut microbiota of mammals possess unique metabolic pathways with untapped therapeutic potential. Using molecular insights into dietary fiber metabolism by the human gut microbiota, we designed a targeted drug delivery system based on bespoke glycoconjugates of a complex plant oligosaccharide called GlycoCaging. GlycoCaging of exemplar anti-inflammatory drugs enabled the release of active molecules triggered by unique glycosidases of autochthonous gut bacteria. GlycoCaging  ensured drug efficacy was potentiated, and off-target effects were eliminated in murine models of inflammatory bowel disease.  Biochemical and metagenomic analyses of gut microbiota of individual humans confirmed the broad applicability of this strategy.